We are live on !
Find out more
AlphaMark Advisors Portfolio holdings
AUM
$231M
Turnover
25.87%
1-Year Est. Return
19.98%
This Fund
S&P 500
This Quarter Est. Return
-0.21%
1 Year Est. Return
+19.98%
3 Year Est. Return
+26.38%
5 Year Est. Return
+72.27%
10 Year Est. Return
+180.76%
AUM
$231M
AUM Growth
-$58.7M
(-20%)
Cap. Flow
-$55.9M
Cap. Flow % of AUM
Cap. Flow %
-24.18%
Top 10 Holdings %
Top 10 Hldgs %
38.54%
Holding
773
New
68
Increased
169
Reduced
108
Closed
132
Avg Time Held
4.2
years
Top 10 Avg Time Held
2.6
years
Top 20 Avg Time Held
3.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$1.09M |
| 2 |
Regan Floating Rate MBS ETF
MBSF
|
+$782K |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$761K |
| 4 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$597K |
| 5 |
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
|
+$591K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AlphaMark Actively Managed Small Cap ETF
SMCP
|
+$29.4M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$639K |
| 3 |
Lumen Technologies, Inc. Common Stock
LUMN
|
+$547K |
| 4 |
IBM
IBM
|
+$539K |
| 5 |
Corcept Therapeutics
CORT
|
+$489K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 62.58% |
| 2 | Technology | 7.52% |
| 3 | Consumer Staples | 5.65% |
| 4 | Financials | 5.28% |
| 5 | Healthcare | 5.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
26
Verizon
VZ
$182B
| $2.08M | 0.9% |
51,937
+64
| +0.1% | +$2.7K |
2013 Q2
46 quarters
|
|
27
Tradeweb Markets
TW
$25.3B
| $2.02M | 0.87% |
15,390
-407
| -3% | -$53.7K |
2024 Q1
3 quarters
|
|
28
Alphabet (Google) Class C
GOOG
$3.9T
| $1.99M | 0.86% |
10,465
-13
| -0.1% | -$2.3K |
2013 Q2
46 quarters
|
|
29
State Street Materials Select Sector SPDR ETF
XLB
$8.06B
| $1.9M | 0.82% |
45,054
+2,006
| +5% | +$92.9K |
2019 Q3
21 quarters
|
|
30
iShares US Technology ETF
IYW
$24.9B
| $1.88M | 0.81% |
11,765
-537
| -4% | -$85K |
2014 Q4
40 quarters
|
|
31
Vertex Pharmaceuticals
VRTX
$132B
| $1.88M | 0.81% |
4,659
+7
| +0.2% | +$3.24K |
2018 Q3
25 quarters
|
|
32
Marathon Petroleum
MPC
$122B
| $1.82M | 0.79% |
13,071
+536
| +4% | +$81.8K |
2013 Q2
46 quarters
|
|
33
Waste Management
WM
$94.2B
| $1.68M | 0.73% |
8,331
+276
| +3% | +$59.3K |
2013 Q2
46 quarters
|
|
34
Kroger
KR
$38.9B
| $1.63M | 0.71% |
26,710
+1,414
| +6% | +$83K |
2013 Q2
46 quarters
|
|
35
Intercontinental Exchange
ICE
$87.4B
| $1.54M | 0.67% |
10,348
+166
| +2% | +$26.3K |
2013 Q2
46 quarters
|
|
36
Western Alliance Bancorporation
WAL
$8.32B
| $1.48M | 0.64% |
17,745
-104
| -0.6% | -$9.15K |
2018 Q1
27 quarters
|
|
37
Take-Two Interactive
TTWO
$37.6B
| $1.39M | 0.6% |
7,555
+111
| +1% | +$19.3K |
2021 Q4
12 quarters
|
|
38
Invesco DB Agriculture Fund
DBA
$1.18B
| $1.32M | 0.57% |
49,590
+3,425
| +7% | +$89.5K |
2022 Q1
11 quarters
|
|
39
Edwards Lifesciences
EW
$52.3B
| $1.31M | 0.57% |
17,740
+201
| +1% | +$14.1K |
2024 Q2
2 quarters
|
|
|
40
IBM
IBM
$236B
| $1.27M | 0.55% |
5,769
-2,422
| -30% | -$539K |
2020 Q3
17 quarters
|
|
41
Leidos
LDOS
$17.5B
| $1.21M | 0.53% |
8,418
+27
| +0.3% | +$4.49K |
2019 Q1
23 quarters
|
|
42
Thermo Fisher Scientific
TMO
$257B
| $1.2M | 0.52% |
2,308
+72
| +3% | +$39.6K |
2019 Q1
23 quarters
|
|
43
Regeneron Pharmaceuticals
REGN
$83.7B
| $1.16M | 0.5% |
1,622
+9
| +0.6% | +$7.55K |
2013 Q2
46 quarters
|
|
44
Quanta Services
PWR
$87B
| $1.15M | 0.5% |
3,640
+45
| +1% | +$14.5K |
2021 Q1
15 quarters
|
|
45
WisdomTree India Earnings Fund ETF
EPI
$1.76B
| $1.12M | 0.48% |
24,620
-300
| -1% | -$14.2K |
2017 Q4
28 quarters
|
|
46
Eastman Chemical
EMN
$7.57B
| $1.11M | 0.48% |
12,183
-295
| -2% | -$30.2K |
2013 Q2
46 quarters
|
|
47
State Street SPDR Portfolio S&P 500 ETF
SPYM
$184B
| $1.11M | 0.48% |
16,125
+621
| +4% | +$43K |
2023 Q3
5 quarters
|
|
48
RTX Corp
RTX
$263B
| $1.09M | 0.47% |
9,436
+315
| +3% | +$38.1K |
2023 Q1
7 quarters
|
|
49
Molina Healthcare
MOH
$10.3B
| $1.09M | 0.47% |
3,744
+136
| +4% | +$42K |
2021 Q1
15 quarters
|
|
50
Global Payments
GPN
$21.5B
| $998K | 0.43% |
8,909
+237
| +3% | +$25.9K |
2019 Q3
21 quarters
|
|
Similar funds
HPFG
GWM
KC
SL
AlphaMark Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, AlphaMark Advisors held 773 positions worth $231M, down 20% from $290M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
AlphaMark Advisors withdrew a net $55.9M in Q4 2024, closing 132 positions and reducing 108 holdings. Its most notable exit was AlphaMark Actively Managed Small Cap ETF, an estimated $29.4M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 63% of assets, up from 58% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, AlphaMark Advisors opened a new position in Toronto Dominion Bank worth $378K.
- AlphaMark Advisors's largest Q4 2024 buy was Toronto Dominion Bank: 7,100 shares worth $378K.
- AlphaMark Advisors added most to State Street Health Care Select Sector SPDR ETF in Q4 2024, an estimated $1.09M increase.
- AlphaMark Advisors's biggest Q4 2024 reduction was iShares Core S&P 500 ETF, cutting an estimated $639K.
- AlphaMark Advisors fully exited AlphaMark Actively Managed Small Cap ETF in Q4 2024, selling an estimated $29.4M.
- AlphaMark Advisors's ten largest holdings make up 39% of its $231M portfolio in Q4 2024.
- AlphaMark Advisors opened 68 new positions and closed 132 in Q4 2024.
- AlphaMark Advisors's portfolio value fell 20% quarter-over-quarter to $231M.
Based on AlphaMark Advisors's 13F filing for Q4 2024, filed 21 Jan 2025.